SIGA Technologies, Inc. (SIGA)
USD 5.92
(11.07%)
USD 5.92
(11.07%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 64.21 Million USD | 63.52% |
| 2022 | 39.27 Million USD | 101.29% |
| 2021 | 19.51 Million USD | -3.73% |
| 2020 | 20.26 Million USD | 109.94% |
| 2019 | 9.65 Million USD | 231.92% |
| 2018 | 2.9 Million USD | -2.52% |
| 2017 | 2.98 Million USD | -88.62% |
| 2016 | 26.2 Million USD | 110.57% |
| 2015 | 12.44 Million USD | -34.64% |
| 2014 | 19.04 Million USD | -7.17% |
| 2013 | 20.51 Million USD | 16.29% |
| 2012 | 17.64 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | -100.0% |
| 2008 | 1.39 Million USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 63.72 Million USD | -0.77% |
| 2024 Q2 | 55.66 Million USD | -12.64% |
| 2023 FY | 64.21 Million USD | 63.52% |
| 2023 Q1 | 42.57 Million USD | 8.41% |
| 2023 Q2 | 50.49 Million USD | 18.6% |
| 2023 Q3 | 64.95 Million USD | 28.62% |
| 2023 Q4 | 64.21 Million USD | -1.13% |
| 2022 Q1 | 16.27 Million USD | -16.57% |
| 2022 Q2 | 16.43 Million USD | 0.95% |
| 2022 Q3 | 31.26 Million USD | 90.25% |
| 2022 Q4 | 39.27 Million USD | 25.63% |
| 2022 FY | 39.27 Million USD | 101.29% |
| 2021 Q4 | 19.51 Million USD | -34.25% |
| 2021 FY | 19.51 Million USD | -3.73% |
| 2021 Q3 | 29.67 Million USD | 51.39% |
| 2021 Q1 | 20.41 Million USD | 0.71% |
| 2021 Q2 | 19.59 Million USD | -3.97% |
| 2020 Q2 | 14 Million USD | -14.29% |
| 2020 Q4 | 20.26 Million USD | 88.56% |
| 2020 Q3 | 10.74 Million USD | -23.27% |
| 2020 FY | 20.26 Million USD | 109.94% |
| 2020 Q1 | 16.34 Million USD | 69.3% |
| 2019 Q1 | 2.01 Million USD | -30.64% |
| 2019 Q3 | 3.93 Million USD | 64.45% |
| 2019 Q2 | 2.39 Million USD | 18.51% |
| 2019 FY | 9.65 Million USD | 231.92% |
| 2019 Q4 | 9.65 Million USD | 145.55% |
| 2018 Q2 | 2.9 Million USD | -2.51% |
| 2018 Q4 | 2.9 Million USD | -0.0% |
| 2018 Q1 | 2.98 Million USD | 0.0% |
| 2018 FY | 2.9 Million USD | -2.52% |
| 2018 Q3 | 2.9 Million USD | 0.0% |
| 2017 Q3 | 2.98 Million USD | -80.65% |
| 2017 FY | 2.98 Million USD | -88.62% |
| 2017 Q1 | 19.11 Million USD | -27.05% |
| 2017 Q2 | 15.41 Million USD | -19.37% |
| 2017 Q4 | 2.98 Million USD | 0.0% |
| 2016 Q1 | 22.84 Million USD | 83.51% |
| 2016 Q4 | 26.2 Million USD | 47.65% |
| 2016 Q3 | 17.75 Million USD | -38.64% |
| 2016 Q2 | 28.93 Million USD | 26.66% |
| 2016 FY | 26.2 Million USD | 110.57% |
| 2015 Q2 | 8.77 Million USD | -40.8% |
| 2015 Q4 | 12.44 Million USD | 1039.9% |
| 2015 Q3 | 1.09 Million USD | -87.55% |
| 2015 FY | 12.44 Million USD | -34.64% |
| 2015 Q1 | 14.81 Million USD | -22.2% |
| 2014 FY | 19.04 Million USD | -7.17% |
| 2014 Q4 | 19.04 Million USD | 5.06% |
| 2014 Q3 | 18.12 Million USD | 7.61% |
| 2014 Q2 | 16.84 Million USD | -1.35% |
| 2014 Q1 | 17.07 Million USD | -16.77% |
| 2013 Q1 | 13.14 Million USD | -25.47% |
| 2013 FY | 20.51 Million USD | 16.29% |
| 2013 Q4 | 20.51 Million USD | 20.76% |
| 2013 Q3 | 16.98 Million USD | -7.94% |
| 2013 Q2 | 18.45 Million USD | 40.34% |
| 2012 Q1 | 923.19 Thousand USD | 0.0% |
| 2012 Q3 | 17.35 Million USD | 95.91% |
| 2012 Q4 | 17.64 Million USD | 1.64% |
| 2012 Q2 | 8.85 Million USD | 859.71% |
| 2012 FY | 17.64 Million USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | 608.45 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2009 FY | - USD | -100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2008 Q4 | 1.39 Million USD | 4.11% |
| 2008 FY | 1.39 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | 84.79 Thousand USD | 0.0% |
| 2008 Q3 | 1.33 Million USD | 1477.58% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q1 | 115.12 Thousand USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | -100.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 100.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q4 | -85.84 Thousand USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -529.221% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 42.248% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -848.712% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 38.46% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1019.81% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1019.81% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -3334.784% |
| Alpha Teknova, Inc. | 11.59 Million USD | -453.893% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -98.622% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | -20.507% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 2.141% |
| Cosmos Health Inc. | 4.78 Million USD | -1240.94% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -7830.569% |
| Embecta Corp. | 152.1 Million USD | 57.779% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -451.372% |
| Procaps Group, S.A. | 96.83 Million USD | 33.681% |
| Theratechnologies Inc. | 6.06 Million USD | -958.66% |
| Harrow Health, Inc. | 10.86 Million USD | -490.948% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -2261.837% |
| Biofrontera Inc. | 10.9 Million USD | -488.727% |
| DURECT Corporation | 2.21 Million USD | -2794.021% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 17.039% |
| Cronos Group Inc. | 30.33 Million USD | -111.669% |
| OptiNose, Inc. | 8.05 Million USD | -697.545% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -6421833600.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -1026.829% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -127.297% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -2298.792% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -1293.215% |
| Radius Health, Inc. | 278.64 Million USD | 76.953% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -1820.826% |
| ProPhase Labs, Inc. | 3.84 Million USD | -1571.917% |
| Phibro Animal Health Corporation | 265.91 Million USD | 75.85% |
| Procaps Group S.A. | 96.83 Million USD | 33.681% |
| Alvotech | 74.43 Million USD | 13.723% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 98.149% |
| Rockwell Medical, Inc. | 5.87 Million USD | -993.823% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -408.338% |
| Tilray Brands, Inc. | 252.08 Million USD | 74.525% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -60.63% |
| Shineco, Inc. | 1.58 Million USD | -3942.639% |
| PetIQ, Inc. | 159.3 Million USD | 59.689% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 42133.759% |
| Incannex Healthcare Limited | -10.01 Million USD | 741.222% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -67.672% |
| Alimera Sciences, Inc. | 1.87 Million USD | -3317.687% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -70.404% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -3887.748% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -1332.486% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -25147.821% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -518.674% |
| Hempacco Co., Inc. | 2.54 Million USD | -2425.668% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 13.723% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -34.365% |
| Lantheus Holdings, Inc. | 64.02 Million USD | -0.296% |
| Currenc Group, Inc. | 732.91 Thousand USD | -8662.092% |
| Kamada Ltd. | 87.74 Million USD | 26.814% |
| Indivior PLC | 141.79 Million USD | 54.712% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -13227.731% |
| Flora Growth Corp. | 8.5 Million USD | -654.799% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -25147.821% |
| Evolus, Inc. | 10.99 Million USD | -483.909% |
| HUTCHMED (China) Limited | 50.25 Million USD | -27.777% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 39.321% |
| Akanda Corp. | 1.28 Million USD | -4890.181% |